Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Δ9-TETRAHYDROCANNABINOL AND 11-HYDROXY-Δ9-TETRAHYDROCANNABINOL: BEHAVIORAL EFFECTS AND TOLERANCE DEVELOPMENT

D. S. Kosersky, D. E. McMillan and L. S. Harris
Journal of Pharmacology and Experimental Therapeutics April 1974, 189 (1) 61-65;
D. S. Kosersky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. E. McMillan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. S. Harris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The effects of intravenous injections of Δ9-tetrahydrocannabinol (Δ9-THC) and its hydroxylated metabolite, 11-hydroxy-Δ9-tetrahydrocannabinol (11-OH-Δ9-THC) were studied in pigeons, whose rates of key pecking were maintained by a variable-interval 3-minute schedule of food presentation. A dose of 0.03 mg/kg of either Δ9-THC or 11-OH-Δ9-THC produced an almost immediate decrease in the rate of key-peck responding, with the rate of responding returning to control levels within 30 to 45 minutes after injection. Doses of 0.1 to 0.3 mg/kg of either Δ9-THC or 11-OH-Δ9-THC completely eliminated responding immediately after injection with a gradual recovery of responding beginning within 60 to 90 minutes (0.1 mg/kg) or 195 to 240 minutes (0.3 mg/kg). The gradual recovery of responding took place over a 60- to 90-minute period for both doses of Δ9-THC and 11-OH-Δ9-THC. Finally, tolerance developed to successive daily injections of 0.3 mg/kg of either Δ9-THC or 11-OH-Δ9-THC over an 8- to 15-day period and a reciprocal cross-tolerance was demonstrated between Δ9-THC and 11-OH-Δ9-THC. On the basis of these effects on the schedule-controlled behavior of pigeons, Δ9-THC and 11-OH-Δ9-THC are indistinguishable.

Footnotes

    • Received July 2, 1973.
    • Accepted December 3, 1973.
  • © 1974 by The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 189, Issue 1
1 Apr 1974
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Δ9-TETRAHYDROCANNABINOL AND 11-HYDROXY-Δ9-TETRAHYDROCANNABINOL: BEHAVIORAL EFFECTS AND TOLERANCE DEVELOPMENT
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Δ9-TETRAHYDROCANNABINOL AND 11-HYDROXY-Δ9-TETRAHYDROCANNABINOL: BEHAVIORAL EFFECTS AND TOLERANCE DEVELOPMENT

D. S. Kosersky, D. E. McMillan and L. S. Harris
Journal of Pharmacology and Experimental Therapeutics April 1, 1974, 189 (1) 61-65;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Δ9-TETRAHYDROCANNABINOL AND 11-HYDROXY-Δ9-TETRAHYDROCANNABINOL: BEHAVIORAL EFFECTS AND TOLERANCE DEVELOPMENT

D. S. Kosersky, D. E. McMillan and L. S. Harris
Journal of Pharmacology and Experimental Therapeutics April 1, 1974, 189 (1) 61-65;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Discriminative Stimulus Effects of Zolpidem in Squirrel Monkeys: Comparison with Conventional Benzodiazepines and Sedative-Hypnotics
  • Use-Dependent ‘Agonist’ Effect of Azimilide on the HERG Channel
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics